The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies

Overview of attention for article published in Annals of Surgical Oncology, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 8 X users

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 31,861 followers.

RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…

Reply Repost Favourite

RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…

Reply Repost Favourite

RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…

Reply Repost Favourite

RT @AnnSurgOncol: JULY ISSUE: The Rationale and Emerging Use of #Neoadjuvant #ImmuneCheckpointBlockade for #SolidMalignancies. https://t.co…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.